Nanalysis Scientific Corp.
NSCIF
$0.1858
$0.00040.22%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.30M | 33.19M | 31.62M | 29.11M | 25.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.30M | 33.19M | 31.62M | 29.11M | 25.91M |
| Cost of Revenue | 22.87M | 23.91M | 24.06M | 22.60M | 21.18M |
| Gross Profit | 9.43M | 9.28M | 7.55M | 6.52M | 4.72M |
| SG&A Expenses | 8.20M | 8.25M | 8.36M | 8.54M | 8.74M |
| Depreciation & Amortization | 2.97M | 3.18M | 3.14M | 3.13M | 3.19M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.32M | 35.74M | 35.85M | 34.62M | 33.48M |
| Operating Income | -2.02M | -2.54M | -4.23M | -5.50M | -7.58M |
| Income Before Tax | -8.88M | -9.87M | -5.37M | -8.94M | -10.73M |
| Income Tax Expenses | 15.40K | -15.60K | 725.50K | 633.10K | 405.20K |
| Earnings from Continuing Operations | -8.90 | -9.86 | -6.09 | -9.58 | -11.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | 0.00 | 166.00K |
| Net Income | -8.90M | -9.86M | -6.09M | -9.58M | -10.97M |
| EBIT | -2.02M | -2.54M | -4.23M | -5.50M | -7.58M |
| EBITDA | -1.34M | -1.13M | -2.78M | -3.40M | -4.76M |
| EPS Basic | -0.08 | -0.09 | -0.06 | -0.09 | -0.11 |
| Normalized Basic EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| EPS Diluted | -0.08 | -0.09 | -0.06 | -0.09 | -0.11 |
| Normalized Diluted EPS | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 452.49M | 442.52M | 430.88M | 419.21M | 405.38M |
| Average Diluted Shares Outstanding | 452.49M | 442.52M | 430.88M | 419.21M | 405.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |